Cynthia Campbell, PhD
Professor
Psychiatry
School of Medicine

Interests

Show all (4) Hide

• health services and policy
• prescription opioids
• Substance use research
• health systems

Websites

Show all (1) Hide

• Division of Research (dor.kaiser.org)

Grants and Projects

Show all (7) Hide

• Health Systems Node of the NIDA Clinical Trials Network, NIH, 2015-2025
• Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence, NIH, 2014-2019
• The Impact of Health Care Reform on Addiction and HIV Services, NIH, 2013-2019
• High Deductible Health Plans: Substance Abuse Service Use and Cost Trajectories, NIH, 2011-2014
• The Impact of Health Care Reform on Addiction and HIV Services, NIH, 2013-2014
• Alcohol Trajectories and Service Use in Young Adults: Nine Years Post Treatment, NIH, 2010-2013
• Patients with Alcohol Problems and Chronic Pain: Use of Alcohol and Pain Services, NIH, 2007-2010

Publications (160)

Top publication keywords:
Analgesics, OpioidDelivery of Health Care, IntegratedChronic PainMarijuana AbuseDrug OverdosePrimary Health CareMarijuana UsePatient Protection and Affordable Care ActBuprenorphineOpiate Substitution TreatmentMedical MarijuanaSubstance Abuse Treatment CentersPrenatal CareOpioid-Related DisordersSubstance-Related Disorders

• Electronic Health Record Monitoring Dashboard and Developmental Screening in Pediatric Patients.
  JAMA network open 2026 Davignon MN, Nugent JR, Campbell CI, Mertens JR
• Health Plan Disenrollment and Mortality After Initiation of Medications for Opioid Use Disorder.
  JAMA psychiatry 2026 Nguyen AP, Binswanger IA, Narwaney KJ, Goodrich G, Christine PJ, Campbell CI, Xu S, Loree AM, Glanz JM
• Burden of all-cause and cause-specific mortality among individuals with medications for treatment of opioid use disorder: A matched cohort study from 4 US health systems, 2012-2021.
  Journal of substance use and addiction treatment 2026 Nguyen AP, Narwaney KJ, Glanz JM, Goodrich G, Campbell CI, Xu S, Loree AM, Christine PJ, Binswanger IA
• Adolescent Cannabis Use After Cannabis Legalization and the COVID-19 Pandemic.
  JAMA network open 2026 Young-Wolff KC, Slama NE, Pacula RL, Padon AA, Silver LD, Sterling SA, Satre DD, Campbell CI, Does MB, Alexeeff SE
• A longitudinal analysis of overall and telehealth addiction treatment utilization three years after pandemic-related policy changes.
  Journal of substance use and addiction treatment 2026 Bhattacharya S, Palzes VA, Does MB, Athale NR, Campbell CI

Show all (155 more) Hide

• Adolescent Cannabis Use and Risk of Psychotic, Bipolar, Depressive, and Anxiety Disorders.
  JAMA health forum 2026 Young-Wolff KC, Cortez CA, Alexeeff SE, Silver LD, Pacula RL, Slama NE, Padon AA, Satre DD, Campbell CI, Koshy MT, Does MB, Sterling SA
• Vaping nicotine is associated with increased medically-attended COVID-19 in women of reproductive age in an integrated health system.
  Journal of thoracic disease 2025 Velotta JB, Moskalenko I, Zhu S, Adams SR, Nugent JR, Chervo T, Skarbinski J, Prochaska JJ, Brown QL, Campbell CI, Soroosh AJ, Does MB, Young-Wolff KC
• Differences in benefits of office based opioid treatment: Secondary analyses across sub-groups in the PROUD randomized controlled implementation trial.
  Addiction (Abingdon, England) 2025 Bradley KA, Hyun N, Idu A, Yu O, Bobb JF, Wartko PD, Weinstein Z, Matthews AG, McCormack J, Lee AK, Samet JH, PROUD Trial collaborators on sex, race and ethnicity
• Cocaine use disorder and risk of acute coronary syndromes in adults with unhealthy drinking.
  Journal of addictive diseases 2025 Towns B, Palzes VA, Sterling S, Go AS, Campbell CI
• Implementation outcomes included in NIDA Clinical Trials Network (CTN) studies: A systematic review of studies conducted over 20 years.
  Journal of substance use and addiction treatment 2025 Gonzalez ST, Horigian VE, Cheng H, Hagedorn HJ, Shmueli-Blumberg D, Campbell CI, Lin C, Rogers E, Baloh J, Hilton R, Vena A, McNeely J, Glass JE
• Polysubstance use in pregnancy: Findings from a population-based cross-sectional cohort study of pregnant women with opioid use.
  Drug and alcohol dependence 2025 Luba R, Comer SD, Sun L, Pimentel SD, Li S, Hedderson M, Campbell CI, Kuzniewicz MW
• Association of preconception cannabis use frequency with cannabis use during early pregnancy.
  BMC pregnancy and childbirth 2025 Young-Wolff KC, Chi FW, Campbell CI, Does MB, Wysota CN, Ansley D, Castellanos C, Lapham GT
• Risks for Adverse Events by Sex and Age After Prescription Opioid Dose Reduction: A Secondary Analysis Across 8 U.S. Health Systems.
  American journal of preventive medicine 2025 Metz VE, Palzes VA, Binswanger IA, Altschuler A, Poulsen MN, Ahmedani BK, Andrade SE, Clark RE, Hechter RC, Horberg MA, Sanchez K, Bailey SR, Stephens KA, Rubinstein AL, Campbell CI
• Prevalence and Sociodemographic Correlates of Blunt Use During Early Pregnancy.
  American journal of preventive medicine 2025 Young-Wolff KC, Cortez CA, Padon AA, Prochaska JJ, Soroosh AJ, Campbell CI, Brown QL
• Risk of self-harm and overdose after starting buprenorphine for opioid use disorder.
  General hospital psychiatry 2025 Simon GE, Shortreed SM, Johnson E, Ahmedani BK, Sterling SA, Campbell CI, Hechter RC, Ziebell RA, Parthasarathy S
• Population-Level Evidence That Alcohol Brief Interventions Improve Drinking and Blood Pressure Outcomes in Patients With Hypertension and Unhealthy Alcohol Use.
  Journal of studies on alcohol and drugs 2025 Sterling SA, Palzes VA, Lu Y, Kline-Simon AH, Ross TB, Weisner CM, Elson J, Satre DD, Awsare S, Asyyed A, Rana J, Campbell CI, Metz VE, Chi FW
• Associations of Local Cannabis Policy and Retail Availability in Northern California with Adverse Adolescent Mental Health Outcomes.
  Substance use & misuse 2025 Silver LD, Slama NE, Dong H, Padon AA, Pacula RL, Alexeeff SE, Sterling SA, Dyer WT, Campbell CI, Satre DD, Lu Y, Does MB, Annam J, Young-Wolff KC
• Monitoring strategies and vancomycin-associated acute kidney injury in patients treated at home.
  The Journal of antimicrobial chemotherapy 2025 Morimoto W, Alavi M, Campbell CI, Silverman M
• A longitudinal observational study with ecological momentary assessment and deep learning to predict non-prescribed opioid use, treatment retention, and medication nonadherence among persons receiving medication treatment for opioid use disorder.
  Journal of substance use and addiction treatment 2025 Heinz MV, Price GD, Singh A, Bhattacharya S, Chen CH, Asyyed A, Does MB, Hassanpour S, Hichborn E, Kotz D, Lambert-Harris CA, Li Z, McLeman B, Mishra V, Stanger C, Subramaniam G, Wu W, Campbell CI, …
• Patterns of substance use and associations with mental health and interpersonal violence among adolescents.
  Addictive behaviors reports 2025 Ogden SN, Cortez C, Sterling SA, Alexeeff SE, Slama NE, Campbell CI, Satre DD, Asyyed AH, Does MB, Altschuler A, Lu Y, Young-Wolff KC
• Frequency of Preconception and Prenatal Cannabis Use and Nausea and Vomiting in Pregnancy.
  Obstetrics and gynecology 2025 Young-Wolff KC, Chi FW, Campbell CI, Alexeeff SE, Ansley D, Vanderziel A, Lapham GT
• Impact of Fascial Plane Block on Postoperative Length of Stay and Opioid Use Among Colectomy Patients Within an Established Enhanced Recovery After Surgery Program: A Retrospective Cohort Study.
  Journal of pain research 2025 Khersonsky J, Alavi M, Yap EN, Campbell CI
• Time to evaluation and characteristics of patients evaluated at epilepsy centers within an integrated health care delivery system.
  Epilepsy & behavior : E&B 2025 Ambrose J, Mahmood N, Campbell CI, Eaton A
• Sociodemographic differences in modes of cannabis use among pregnant individuals in Northern California.
  Drug and alcohol dependence 2024 Young-Wolff KC, Cortez CA, Nugent JR, Padon AA, Prochaska JJ, Adams SR, Slama NE, Soroosh AJ, Does MB, Campbell CI, Ansley D, Castellanos C, Brown QL
• Predictors of Participation in Prenatal Substance Use Assessment, Counseling, and Treatment Among Pregnant Individuals in Prenatal Settings Who Use Cannabis.
  Journal of addiction medicine 2024 Lapham GT, Chi FW, Young-Wolff KC, Ansley D, Castellanos C, Does MB, Asyyed AH, Ettenger A, Campbell CI
• Clinician perspectives on barriers and facilitators to the treatment of adolescent cannabis use: A qualitative study.
  Journal of substance use and addiction treatment 2024 Mian MN, Annam J, Altschuler A, Does MB, Sterling SA, Satre DD, Campbell CI, Asyyed AH, Silver LD, Cunningham SF, Young-Wolff KC
• Associations between adverse childhood experiences, resilience, and excess gestational weight gain.
  American journal of obstetrics & gynecology MFM 2024 Watson CR, Eaton A, Campbell CI, Hedderson MM, Ridout KK, Alexeeff SE, Young-Wolff KC
• Association of Local Cannabis Policy and Retail Availability With Cannabis Use and Problematic Cannabis Use Among Adolescents in Northern California.
  American journal of public health 2024 Young-Wolff KC, Asera A, Padon AA, Slama NE, Alexeeff SE, Pacula RL, Campbell CI, Sterling SA, Satre DD, Lu Y, Dyer WT, Does MB, Silver LD
• Cannabis Use During Early Pregnancy Following Recreational Cannabis Legalization.
  JAMA health forum 2024 Young-Wolff KC, Slama NE, Avalos LA, Padon AA, Silver LD, Adams SR, Does MB, Ansley D, Castellanos C, Campbell CI, Alexeeff SE
• Clinical Use of Mental Health Digital Therapeutics in a Large Health Care Delivery System: Retrospective Patient Cohort Study and Provider Survey.
  JMIR mental health 2024 Ridout SJ, Ridout KK, Lin TY, Campbell CI
• Prospective changes in drinking during the COVID-19 pandemic among adults with unhealthy alcohol use.
  Alcohol and alcoholism (Oxford, Oxfordshire) 2024 Palzes VA, Chi FW, Satre DD, Kline-Simon AH, Campbell CI, Weisner C, Sterling S
• Changes in Prenatal Cannabis Use Among Pregnant Individuals From 2012 to 2022.
  Obstetrics and gynecology 2024 Young-Wolff KC, Chi FW, Lapham GT, Alexeeff SE, Does MB, Ansley D, Campbell CI
• Prevalence and trends of suspected cannabinoid hyperemesis syndrome over an 11-year period in Northern California: An electronic health record study.
  Drug and alcohol dependence 2024 Costales B, Lu Y, Young-Wolff KC, Cotton DM, Campbell CI, Iturralde E, Sterling SA
• Association of psychiatric and substance use disorders with cannabis use and cannabis use disorder during early pregnancy in northern California.
  Addiction (Abingdon, England) 2024 Young-Wolff KC, Chi FW, Campbell CI, Does MB, Brown QL, Alexeeff SE, Ansley D, Wang X, Lapham GT
• Opioid Administration Practice Patterns in Patients With Acute Respiratory Failure Who Undergo Invasive Mechanical Ventilation.
  Critical care explorations 2024 Myers LC, Bosch NA, Soltesz L, Daly KA, Campbell CI, Schwager E, Salvati E, Stevens JP, Wunsch H, Rucci JM, Jafarzadeh SR, Liu VX, Walkey AJ
• Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial.
  Drug and alcohol dependence 2024 Bobb JF, Idu AE, Qiu H, Yu O, Boudreau DM, Wartko PD, Matthews AG, McCormack J, Lee AK, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Northrup TF, Braciszewski JM, Murphy MT, Arnsten JH, …
• Intravenous Opioid Administration During Mechanical Ventilation and Use After Hospital Discharge.
  JAMA network open 2024 Myers LC, Soltesz L, Bosch N, Daly KA, Devis Y, Rucci J, Stevens J, Wunsch H, Jafarzadeh SR, Campbell CI, Liu VX, Walkey AJ
• Unhealthy Alcohol Use Among Adults With Depression or Anxiety: Changes During COVID-19 and Associations With Mental Health Treatment.
  Journal of studies on alcohol and drugs 2024 Satre DD, Palzes VA, Chi FW, Kline-Simon AH, Campbell CI, van Doren N, Weisner C, Sterling S
• Clinician perspectives on adolescent cannabis-related beliefs and behaviors following recreational cannabis legalization.
  Addictive behaviors 2024 Young-Wolff KC, Does MB, Mian MN, Sterling SA, Satre DD, Campbell CI, Silver LD, Alexeeff SE, Cunningham SF, Asyyed A, Altschuler A
• Self-reported pain severity and use of cannabis and opioids in persons with HIV in an urban primary care setting in Northern California: A cross-sectional study.
  Medicine 2024 Kim HJ, Satre DD, Leyden W, Leibowitz AS, Campbell CI, Silverberg MJ
• Association of Adverse Childhood Experiences and Resilience With Depression and Anxiety During Pregnancy.
  Obstetrics and gynecology 2024 Watson CR, Eaton A, Campbell CI, Alexeeff SE, Avalos LA, Ridout KK, Young-Wolff KC
• Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus.
  Addiction science & clinical practice 2024 Rush AJ, Gore-Langton RE, Bart G, Bradley KA, Campbell CI, McKay J, Oslin DW, Saxon AJ, Winhusen TJ, Wu LT, Moran LM, Tai B
• Addiction Medicine Treatment Utilization by Race/Ethnicity Among Adolescents With Substance Use Problems Before Versus During the COVID-19 Pandemic.
  The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2024 Palzes VA, Chi FW, Metz VE, Sterling S, Asyyed A, Ridout KK, Campbell CI
• A patient activation intervention in primary care for patients with chronic pain on long term opioid therapy: results from a randomized control trial.
  BMC health services research 2024 Does MB, Adams SR, Kline-Simon AH, Marino C, Charvat-Aguilar N, Weisner CM, Rubinstein AL, Ghadiali M, Cowan P, Young-Wolff KC, Campbell CI
• Association of initial opioid prescription duration and an opioid refill by pain diagnosis: Evidence from outpatient settings in ten US health systems.
  Preventive medicine 2023 Nguyen AP, Palzes VA, Binswanger IA, Ahmedani BK, Altschuler A, Andrade SE, Bailey SR, Clark RE, Haller IV, Hechter RC, Karmali R, Metz VE, Poulsen MN, Roblin DW, Rosa CL, Rubinstein AL, Sanchez K, …
• Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial.
  JAMA internal medicine 2023 Wartko PD, Bobb JF, Boudreau DM, Matthews AG, McCormack J, Lee AK, Qiu H, Yu O, Hyun N, Idu AE, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Labelle CT, Zare-Mehrjerdi M, Stotts AL, …
• Prescription Opioid Dose Reductions and Potential Adverse Events: a Multi-site Observational Cohort Study in Diverse US Health Systems.
  Journal of general internal medicine 2023 Metz VE, Ray GT, Palzes V, Binswanger I, Altschuler A, Karmali RN, Ahmedani BK, Andrade SE, Boscarino JA, Clark RE, Haller IV, Hechter RC, Roblin DW, Sanchez K, Bailey SR, McCarty D, Stephens KA, Rosa…
• Telemedicine-delivered treatment for substance use disorder: A scoping review.
  Journal of telemedicine and telecare 2023 Pham H, Lin C, Zhu Y, Clingan SE, Lin LA, Mooney LJ, Murphy SM, Campbell CI, Liu Y, Hser YI
• Patient Engagement in a Multimodal Digital Phenotyping Study of Opioid Use Disorder.
  Journal of medical Internet research 2023 Campbell CI, Chen CH, Adams SR, Asyyed A, Athale NR, Does MB, Hassanpour S, Hichborn E, Jackson-Morris M, Jacobson NC, Jones HK, Kotz D, Lambert-Harris CA, Li Z, McLeman B, Mishra V, Stanger C, …
• Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder - a narrative review.
  Journal of addictive diseases 2023 Arenson A, Campbell CI, Remler I
• Overall and Telehealth Addiction Treatment Utilization by Age, Race, Ethnicity, and Socioeconomic Status in California After COVID-19 Policy Changes.
  JAMA health forum 2023 Palzes VA, Chi FW, Metz VE, Sterling S, Asyyed A, Ridout KK, Campbell CI
• Cannabis Use for Medical Reasons Among Patients in a Large California Health Care System After Legalization of Nonmedical Use.
  Journal of studies on alcohol and drugs 2023 Karmali RN, Does MB, Gordon NP, Sterling SA, Young-Wolff KC, Sidney S, Campbell CI
• Disparities in the receipt of alcohol brief intervention: The intersectionality of sex, age, and race/ethnicity.
  Addiction (Abingdon, England) 2023 Parthasarathy S, Chi FW, Metz V, Kline-Simon A, Asyyed A, Campbell CI, Sterling S
• Tobacco Smoking and Risk of SARS-CoV-2 Infection and Disease Severity Among Adults in an Integrated Healthcare System in California.
  Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2023 Young-Wolff KC, Slama N, Alexeeff SE, Sakoda LC, Fogelberg R, Myers LC, Campbell CI, Adams AS, Prochaska JJ
• Baseline representativeness of patients in clinics enrolled in the PRimary care Opioid Use Disorders treatment (PROUD) trial: comparison of trial and non-trial clinics in the same health systems.
  BMC health services research 2022 Wartko PD, Qiu H, Idu AE, Yu O, McCormack J, Matthews AG, Bobb JF, Saxon AJ, Campbell CI, Liu D, Braciszewski JM, Murphy SM, Burganowski RP, Murphy MT, Horigian VE, Hamilton LK, Lee AK, Boudreau DM, …
• COVID-19 pandemic-related changes in utilization of telehealth and treatment overall for alcohol use problems.
  Alcoholism, clinical and experimental research 2022 Palzes VA, Chi FW, Metz VE, Campbell C, Corriveau C, Sterling S
• Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States.
  Drug and alcohol dependence 2022 Lin C, Pham H, Zhu Y, Clingan SE, Lin LA, Murphy SM, Campbell CI, Sorrell TR, Liu Y, Mooney LJ, Hser YI
• Geographic Accessibility of Retail Cannabis in Northern California and Prenatal Cannabis Use During the COVID-19 Pandemic.
  JAMA network open 2022 Young-Wolff KC, Slama NE, Padon AA, Silver LD, Soroosh A, Alexeeff SE, Adams SR, Does MB, Campbell CI, Ansley D, Conway A, Goler N, Avalos LA
• Patterns of Health Care Use 5 Years After an Intervention Linking Patients in Addiction Treatment With a Primary Care Practitioner.
  JAMA network open 2022 Iturralde E, Weisner CM, Adams SR, Chi FW, Ross TB, Cunningham SF, Ghadiali M, Asyyed AH, Satre DD, Campbell CI, Sterling SA
• Development and Testing of a Communication Intervention to Improve Chronic Pain Management in Primary Care: A Pilot Randomized Clinical Trial.
  The Clinical journal of pain 2022 Henry SG, Fenton JJ, Campbell CI, Sullivan M, Weinberg G, Naz H, Graham WM, Dossett ML, Kravitz RL
• Accuracy of diagnostic codes for prenatal opioid exposure and neonatal opioid withdrawal syndrome.
  Journal of perinatology : official journal of the California Perinatal Association 2022 Kuzniewicz MW, Campbell CI, Li S, Walsh EM, Croen LA, Comer SD, Pimentel SD, Hedderson M, Sun LS
• The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment.
  Addiction (Abingdon, England) 2022 Glanz JM, Binswanger IA, Clarke CL, Nguyen AP, Ford MA, Ray GT, Xu S, Hechter RC, Yarborough BJH, Roblin DW, Ahmedani B, Boscarino JA, Andrade SE, Rosa CL, Campbell CI
• Alcohol Use Among Young Adults in Northern California During the COVID-19 Pandemic-An Electronic Health Records-Based Study.
  Frontiers in psychiatry 2022 Metz VE, Palzes VA, Chi FW, Campbell CI, Sterling SA
• Sex Differences in Comorbid Mental and Substance Use Disorders Among Primary Care Patients With Opioid Use Disorder.
  Psychiatric services (Washington, D.C.) 2022 Braciszewski JM, Idu AE, Yarborough BJH, Stumbo SP, Bobb JF, Bradley KA, Rossom RC, Murphy MT, Binswanger IA, Campbell CI, Glass JE, Matson TE, Lapham GT, Loree AM, Barbosa-Leiker C, Hatch MA, Tsui JI…
• Development and implementation of a prescription opioid registry across diverse health systems.
  JAMIA open 2022 Ray GT, Altschuler A, Karmali R, Binswanger I, Glanz JM, Clarke CL, Ahmedani B, Andrade SE, Boscarino JA, Clark RE, Haller IV, Hechter R, Roblin DW, Sanchez K, Yarborough BJ, Bailey SR, McCarty D, …
• Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients.
  JAMA network open 2022 Lapham GT, Matson TE, Carrell DS, Bobb JF, Luce C, Oliver MM, Ghitza UE, Hsu C, Browne KC, Binswanger IA, Campbell CI, Saxon AJ, Vandrey R, Schauer GL, Pacula RL, Horberg MA, Bailey SR, McClure EA, …
• The Feasibility and Utility of Harnessing Digital Health to Understand Clinical Trajectories in Medication Treatment for Opioid Use Disorder: D-TECT Study Design and Methodological Considerations.
  Frontiers in psychiatry 2022 Marsch LA, Chen CH, Adams SR, Asyyed A, Does MB, Hassanpour S, Hichborn E, Jackson-Morris M, Jacobson NC, Jones HK, Kotz D, Lambert-Harris CA, Li Z, McLeman B, Mishra V, Stanger C, Subramaniam G, Wu W…
• The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus study.
  Addiction (Abingdon, England) 2022 Karnik NS, Marsden J, McCluskey C, Boley RA, Bradley KA, Campbell CI, Curtis ME, Fiellin D, Ghitza U, Hefner K, Hser YI, McHugh RK, McPherson SM, Mooney LJ, Moran LM, Murphy SM, Schwartz RP, Shmueli-…
• Alcohol brief intervention, specialty treatment and drinking outcomes at 12 months: Results from a systematic alcohol screening and brief intervention initiative in adult primary care.
  Drug and alcohol dependence 2022 Chi FW, Parthasarathy S, Palzes VA, Kline-Simon AH, Metz VE, Weisner C, Satre DD, Campbell CI, Elson J, Ross TB, Lu Y, Sterling SA
• Substance use disorders among primary care patients screening positive for unhealthy alcohol use.
  Family practice 2022 Metz VE, Palzes VA, Kline-Simon AH, Chi FW, Campbell CI, Weisner CM, Sterling SA
• Mortality Among Patients Prescribed Buprenorphine for Opioid Use Disorder After Disenrollment from an Insurance Plan and Healthcare System.
  Journal of general internal medicine 2022 Nguyen AP, Glanz JM, Shoup JA, Campbell CI, Clarke CL, Ford MA, Binswanger IA
• Clinical documentation of patient-reported medical cannabis use in primary care: Toward scalable extraction using natural language processing methods.
  Substance abuse 2022 Carrell DS, Cronkite DJ, Shea M, Oliver M, Luce C, Matson TE, Bobb JF, Hsu C, Binswanger IA, Browne KC, Saxon AJ, McCormack J, Jelstrom E, Ghitza UE, Campbell CI, Bradley KA, Lapham GT
• Patient and provider factors associated with receipt and delivery of brief interventions for unhealthy alcohol use in primary care.
  Alcoholism, clinical and experimental research 2021 Lu Y, Chi FW, Parthasarathy S, Palzes VA, Kline-Simon AH, Metz VE, Weisner C, Satre DD, Campbell CI, Elson J, Ross TB, Awsare SV, Sterling SA
• Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems.
  Addiction science & clinical practice 2021 Bagley SM, Chavez L, Braciszewski JM, Akolsile M, Boudreau DM, Lapham G, Campbell CI, Bart G, Yarborough BJH, Samet JH, Saxon AJ, Rossom RC, Binswanger IA, Murphy MT, Glass JE, Bradley KA, PROUD …
• Attention-Deficit/Hyperactivity Disorder Medication Adherence in the Transition to Adulthood: Associated Adverse Outcomes for Females and Other Disparities.
  The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2021 Rao K, Carpenter DM, Campbell CI
• Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington State.
  JAMA network open 2021 Matson TE, Carrell DS, Bobb JF, Cronkite DJ, Oliver MM, Luce C, Ghitza UE, Hsu CW, Campbell CI, Browne KC, Binswanger IA, Saxon AJ, Bradley KA, Lapham GT
• Changes in Diagnostic and Demographic Characteristics of Patients Seeking Mental Health Care During the Early COVID-19 Pandemic in a Large, Community-Based Health Care System.
  The Journal of clinical psychiatry 2021 Ridout KK, Alavi M, Ridout SJ, Koshy MT, Harris B, Dhillon I, Awsare S, Weisner CM, Campbell CI, Iturralde E
• Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV.
  Journal of general internal medicine 2021 Tsui JI, Akosile MA, Lapham GT, Boudreau DM, Johnson EA, Bobb JF, Binswanger IA, Yarborough BJH, Glass JE, Rossom RC, Murphy MT, Cunningham CO, Arnsten JH, Thakral M, Saxon AJ, Merrill JO, Samet JH, …
• PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
  Addiction science & clinical practice 2021 Campbell CI, Saxon AJ, Boudreau DM, Wartko PD, Bobb JF, Lee AK, Matthews AG, McCormack J, Liu DS, Addis M, Altschuler A, Samet JH, LaBelle CT, Arnsten J, Caldeiro RM, Borst DT, Stotts AL, Braciszewski…
• Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study.
  Trials 2021 Karnik NS, Campbell CI, Curtis ME, Fiellin DA, Ghitza U, Hefner K, Hser YI, McHugh RK, Murphy SM, McPherson SM, Moran L, Mooney LJ, Wu LT, Shmueli-Blumberg D, Shulman M, Schwartz RP, Stephens KA, …
• Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies.
  Journal of addiction medicine 2020 Satre DD, Iturralde E, Ghadiali M, Young-Wolff KC, Campbell CI, Leibowitz AS, Sterling SA
• Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study.
  BMC health services research 2020 Satre DD, Parthasarathy S, Silverberg MJ, Horberg M, Young-Wolff KC, Williams EC, Volberding P, Campbell CI
• Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system.
  Journal of substance abuse treatment 2020 Satre DD, Palzes VA, Young-Wolff KC, Parthasarathy S, Weisner C, Guydish J, Campbell CI
• Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.
  Journal of substance abuse treatment 2020 Boudreau DM, Lapham G, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Campbell CI, Rossom RC, Binswanger IA, Yarborough BJ, Arnsten JH, Cunningham CO, Glass JE, Murphy MT, Zare M, Hechter RC, …
• The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network.
  Journal of substance abuse treatment 2020 Marsch LA, Campbell A, Campbell C, Chen CH, Ertin E, Ghitza U, Lambert-Harris C, Hassanpour S, Holtyn AF, Hser YI, Jacobs P, Klausner JD, Lemley S, Kotz D, Meier A, McLeman B, McNeely J, Mishra V, …
• The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose.
  Drug and alcohol dependence 2020 Karmali RN, Ray GT, Rubinstein AL, Sterling SA, Weisner CM, Campbell CI
• Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness.
  BMC psychiatry 2020 Owen-Smith A, Stewart C, Sesay MM, Strasser SM, Yarborough BJ, Ahmedani B, Miller-Matero LR, Waring SC, Haller IV, Waitzfelder BE, Sterling SA, Campbell CI, Hechter RC, Zeber JE, Copeland LA, Scherrer…
• Long-term opioid therapy definitions and predictors: A systematic review.
  Pharmacoepidemiology and drug safety 2019 Karmali RN, Bush C, Raman SR, Campbell CI, Skinner AC, Roberts AW
• Benzodiazepine and unhealthy alcohol use among adult outpatients.
  The American journal of managed care 2019 Hirschtritt ME, Palzes VA, Kline-Simon AH, Kroenke K, Campbell CI, Sterling SA
• Postoperative Opioid Use Before and After Enhanced Recovery After Surgery Program Implementation.
  Annals of surgery 2019 Liu VX, Eaton A, Lee DC, Reyes VM, Paulson SS, Campbell CI, Avins AL, Parodi SM
• Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
  Drug and alcohol dependence 2019 Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Saxon AJ, Campbell CI, Glass JE, Rossom RC, Murphy MT, Binswanger IA, Yarborough BJH, Bradley KA, PROUD …
• Enhanced Recovery After Surgery to Change Process Measures and Reduce Opioid Use After Cesarean Delivery: A Quality Improvement Initiative.
  Obstetrics and gynecology 2019 Hedderson M, Lee D, Hunt E, Lee K, Xu F, Mustille A, Galin J, Campbell C, Quesenberry C, Reyes V, Huang M, Nicol B, Paulson S, Liu V
• Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and drug treatment initiation and engagement among people living with the human immunodeficiency virus (HIV) and patients without an HIV diagnosis.
  Substance abuse 2019 Hechter RC, Horberg MA, Weisner C, Campbell CI, Contreras R, Chen LH, Yarborough BJH, Lapham GT, Haller IV, Ahmedani BK, Binswanger IA, Kline-Simon AH, Satre DD
• Disparities in knowledge and use of tobacco treatment among smokers in California following healthcare reform.
  Preventive medicine reports 2019 Young-Wolff KC, Adams SR, Tan ASL, Adams AS, Klebaner D, Campbell CI, Satre DD, Salloum RG, Carter-Harris L, Prochaska JJ
• Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings.
  Substance abuse 2019 Kline-Simon AH, Stumbo SP, Campbell CI, Binswanger IA, Weisner C, Haller IV, Hechter RC, Ahmedani BK, Lapham GT, Loree AM, Sterling SA, Yarborough BJH
• Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems.
  Substance abuse 2019 Loree AM, Yeh HH, Satre DD, Kline-Simon AH, Yarborough BJH, Haller IV, Campbell CI, Lapham GT, Hechter RC, Binswanger IA, Weisner C, Ahmedani BK
• Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014-2015.
  Substance abuse 2019 Weisner C, Campbell CI, Altschuler A, Yarborough BJH, Lapham GT, Binswanger IA, Hechter RC, Ahmedani BK, Haller IV, Sterling SA, McCarty D, Satre DD, Kline-Simon AH
• Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems.
  Substance abuse 2019 Campbell CI, Weisner C, Binswanger IA, Lapham GT, Ahmedani BK, Yarborough BJH, Haller IV, Altschuler A, Hechter RC, Loree AM, Kline-Simon AH
• The association between medical comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders.
  Substance abuse 2019 Binswanger IA, Carroll NM, Ahmedani BK, Campbell CI, Haller IV, Hechter RC, McNeely J, Yarborough BJH, Kline-Simon AH, Satre DD, Weisner C, Lapham GT
• The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.
  Substance abuse 2019 Lapham GT, Campbell CI, Yarborough BJH, Hechter RC, Ahmedani BK, Haller IV, Kline-Simon AH, Satre DD, Loree AM, Weisner C, Binswanger IA
• Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009-2016.
  Drug and alcohol dependence 2019 Young-Wolff KC, Sarovar V, Tucker LY, Avalos LA, Alexeeff S, Conway A, Armstrong MA, Weisner C, Campbell CI, Goler N
• Evaluating the Impact of Eliminating Copayments for Tobacco Cessation Pharmacotherapy.
  Medical care 2018 Young-Wolff KC, Adams SR, Klebaner D, Adams AS, Campbell CI, Satre DD, Prochaska JJ
• A Quality Framework for Emergency Department Treatment of Opioid Use Disorder.
  Annals of emergency medicine 2018 Samuels EA, D'Onofrio G, Huntley K, Levin S, Schuur JD, Bart G, Hawk K, Tai B, Campbell CI, Venkatesh AK
• Characteristics of patients with substance use disorder before and after the Affordable Care Act.
  Drug and alcohol dependence 2018 Campbell CI, Parthasarathy S, Altschuler A, Young-Wolff KC, Satre DD
• Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization.
  Journal of affective disorders 2018 Bahorik AL, Sterling SA, Campbell CI, Weisner C, Ramo D, Satre DD
• Patient and System Characteristics Associated with Performance on the HEDIS Measures of Alcohol and Other Drug Treatment Initiation and Engagement.
  Journal of addiction medicine 2018 Yarborough BJH, Chi FW, Green CA, Hinman A, Mertens J, Beck A, Horberg M, Weisner C, Campbell CI
• Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system.
  Preventive medicine 2018 Campbell CI, Bahorik AL, VanVeldhuisen P, Weisner C, Rubinstein AL, Ray GT
• Alcohol and Drug Use, Pain and Psychiatric Symptoms among Adults Seeking Outpatient Psychiatric Treatment: Latent Class Patterns and Relationship to Health Status.
  Journal of psychoactive drugs 2017 Ramo DE, Bahorik AL, Delucchi KL, Campbell CI, Satre DD
• Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder.
  Psychiatry research 2017 Bahorik AL, Campbell CI, Sterling SA, Leibowitz A, Travis A, Weisner CM, Satre DD
• Alcohol, marijuana, and opioid use disorders: 5-Year patterns and characteristics of emergency department encounters.
  Substance abuse 2017 Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Young-Wolff KC, Campbell CI
• Smoking Status and Opioid-related Problems and Concerns Among Men and Women on Chronic Opioid Therapy.
  The Clinical journal of pain 2017 Young-Wolff KC, Klebaner D, Weisner C, Von Korff M, Campbell CI
• Serious mental illness and medical comorbidities: Findings from an integrated health care system.
  Journal of psychosomatic research 2017 Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Campbell CI
• The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study.
  Drug and alcohol dependence 2017 Campbell CI, Bahorik AL, Kline-Simon AH, Satre DD
• Association of the Affordable Care Act With Smoking and Tobacco Treatment Utilization Among Adults Newly Enrolled in Health Care.
  Medical care 2017 Young-Wolff KC, Klebaner D, Campbell CI, Weisner C, Satre DD, Adams AS
• Prescription opioid registry protocol in an integrated health system.
  The American journal of managed care 2017 Ray GT, Bahorik AL, VanVeldhuisen PC, Weisner CM, Rubinstein AL, Campbell CI
• Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System.
  Journal of psychoactive drugs 2017 Campbell CI, Parthasarathy S, Young-Wolff KC, Satre DD
• The high price of depression: Family members' health conditions and health care costs.
  General hospital psychiatry 2017 Ray GT, Weisner CM, Taillac CJ, Campbell CI
• Alcohol and Drug Use and Aberrant Drug-Related Behavior Among Patients on Chronic Opioid Therapy.
  Substance use & misuse 2017 Campbell CI, Kline-Simon AH, Von Korff M, Saunders KW, Weisner C
• Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records.
  Pharmacoepidemiology and drug safety 2017 Green CA, Perrin NA, Janoff SL, Campbell CI, Chilcoat HD, Coplan PM
• Socioeconomic differences in adolescent substance abuse treatment participation and long-term outcomes.
  Addictive behaviors 2017 Lui CK, Sterling SA, Chi FW, Lu Y, Campbell CI
• Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System.
  Journal of addiction medicine 2017 Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Campbell CI
• Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics.
  Journal of acquired immune deficiency syndromes (1999) 2016 Satre DD, Altschuler A, Parthasarathy S, Silverberg MJ, Volberding P, Campbell CI
• Marijuana use and service utilization among adolescents 7 years post substance use treatment.
  Drug and alcohol dependence 2016 Campbell CI, Sterling S, Chi FW, Kline-Simon AH
• Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties.
  BMC pharmacology & toxicology 2016 Janoff SL, Perrin NA, Coplan PM, Chilcoat HD, Campbell CI, Green CA
• Demographic, Insurance, and Health Characteristics of Newly Enrolled HIV-Positive Patients After Implementation of the Affordable Care Act in California.
  American journal of public health 2016 Satre DD, Parthasarathy S, Altschuler A, Silverberg MJ, Storholm E, Campbell CI
• High-Deductible Health Plans: Implications for Substance Use Treatment.
  Health services research 2016 Parthasarathy S, Campbell CI
• Physician versus non-physician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: the ADVISe cluster randomized controlled implementation trial.
  Addiction science & clinical practice 2015 Mertens JR, Chi FW, Weisner CM, Satre DD, Ross TB, Allen S, Pating D, Campbell CI, Lu YW, Sterling SA
• Sex and Age Differences in Global Pain Status Among Patients Using Opioids Long Term for Chronic Noncancer Pain.
  Journal of women's health (2002) 2015 LeResche L, Saunders K, Dublin S, Thielke S, Merrill JO, Shortreed SM, Campbell C, Von Korff MR
• Do patient-perceived pros and cons of opioids predict sustained higher-dose use?
  The Clinical journal of pain 2014 Thielke SM, Turner JA, Shortreed SM, Saunders K, Leresche L, Campbell CI, Weisner CC, Korff MV
• 12-step participation and outcomes over 7 years among adolescent substance use patients with and without psychiatric comorbidity.
  Substance abuse 2013 Chi FW, Sterling S, Campbell CI, Weisner C
• Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients.
  General hospital psychiatry 2012 Merrill JO, Von Korff M, Banta-Green CJ, Sullivan MD, Saunders KW, Campbell CI, Weisner C
• Depression and ambivalence toward chronic opioid therapy for chronic noncancer pain.
  The Clinical journal of pain 2012 Howe CQ, Sullivan MD, Saunders KW, Merrill JO, Banta-Green CJ, Weisner C, Campbell CI, Von Korff M
• Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse.
  Annals of family medicine 2012 Grattan A, Sullivan MD, Saunders KW, Campbell CI, Von Korff MR
• 12-Step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment.
  Drug and alcohol dependence 2012 Mundt MP, Parthasarathy S, Chi FW, Sterling S, Campbell CI
• Peer influences on adolescent alcohol and other drug use outcomes.
  Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing 2012 Ramirez R, Hinman A, Sterling S, Weisner C, Campbell C
• Twelve-Step attendance trajectories over 7 years among adolescents entering substance use treatment in an integrated health plan.
  Addiction (Abingdon, England) 2012 Chi FW, Campbell CI, Sterling S, Weisner C
• Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors.
  The journal of pain 2012 Saunders KW, Von Korff M, Campbell CI, Banta-Green CJ, Sullivan MD, Merrill JO, Weisner C
• Functional disability among chronic pain patients receiving long-term opioid treatment.
  Journal of social work in disability & rehabilitation 2012 Valkanoff TA, Kline-Simon AH, Sterling S, Campbell C, Von Korff M
• Prescription long-term opioid use in HIV-infected patients.
  The Clinical journal of pain 2012 Silverberg MJ, Ray GT, Saunders K, Rutter CM, Campbell CI, Merrill JO, Sullivan MD, Banta-Green CJ, Von Korff M, Weisner C
• Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy.
  Pain 2011 Von Korff M, Merrill JO, Rutter CM, Sullivan M, Campbell CI, Weisner C
• Age and gender trends in long-term opioid analgesic use for noncancer pain.
  American journal of public health 2010 Campbell CI, Weisner C, Leresche L, Ray GT, Saunders K, Sullivan MD, Banta-Green CJ, Merrill JO, Silverberg MJ, Boudreau D, Satre DD, Von Korff M
• Opioid prescriptions for chronic pain and overdose: a cohort study.
  Annals of internal medicine 2010 Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M
• Ethnic disparities in accessing treatment for depression and substance use disorders in an integrated health plan.
  International journal of psychiatry in medicine 2010 Satre DD, Campbell CI, Gordon NS, Weisner C
• Trends in long-term opioid therapy for chronic non-cancer pain.
  Pharmacoepidemiology and drug safety 2009 Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C
• Trends in long-term opioid therapy for noncancer pain among persons with a history of depression.
  General hospital psychiatry 2009 Braden JB, Sullivan MD, Ray GT, Saunders K, Merrill J, Silverberg MJ, Rutter CM, Weisner C, Banta-Green C, Campbell C, Von Korff M
• Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders.
  Pain 2009 Weisner CM, Campbell CI, Ray TG, Saunders K, Merrill JO, Banta-Green C, Sullivan MD, Silverberg MJ, Mertens JR, Boudreau D, Von Korff M
• Three-year chemical dependency and mental health treatment outcomes among adolescents: the role of continuing care.
  Alcoholism, clinical and experimental research 2009 Sterling S, Chi F, Campbell C, Weisner C
• Twelve-Step affiliation and 3-year substance use outcomes among adolescents: social support and religious service attendance as potential mediators.
  Addiction (Abingdon, England) 2009 Chi FW, Kaskutas LA, Sterling S, Campbell CI, Weisner C
• Organizational determinants of outpatient substance abuse treatment duration in women.
  Journal of substance abuse treatment 2008 Campbell CI, Alexander JA, Lemak CH
• Self-initiated tobacco cessation and substance use outcomes among adolescents entering substance use treatment in a managed care organization.
  Addictive behaviors 2008 Campbell CI, Chi F, Sterling S, Kohn C, Weisner C
• De facto long-term opioid therapy for noncancer pain.
  The Clinical journal of pain 2008 Von Korff M, Korff MV, Saunders K, Thomas Ray G, Boudreau D, Campbell C, Merrill J, Sullivan MD, Rutter CM, Silverberg MJ, Banta-Green C, Weisner C
• Tailoring of outpatient substance abuse treatment to women, 1995-2005.
  Medical care 2007 Campbell CI, Wells R, Alexander JA, Jiang L, Nahra TA, Lemak CH
• Tailored treatment in the outpatient substance abuse treatment sector: 1995-2005.
  Journal of substance abuse treatment 2007 Alexander JA, Nahra TA, Lemak CH, Pollack H, Campbell CI
• Do licensing and accreditation matter in outpatient substance abuse treatment programs?
  Journal of substance abuse treatment 2007 Wells R, Lemak CH, Alexander JA, Nahra TA, Ye Y, Campbell CI
• Adolescents entering chemical dependency treatment in private managed care: ethnic differences in treatment initiation and retention.
  The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2006 Campbell CI, Weisner C, Sterling S
• Availability of services for women in outpatient substance abuse treatment: 1995-2000.
  The journal of behavioral health services & research 2006 Campbell CI, Alexander JA
• Health services for women in outpatient substance abuse treatment.
  Health services research 2005 Campbell CI, Alexander JA
• Changes in managed care activity in outpatient substance abuse treatment organizations, 1995-2000.
  The journal of behavioral health services & research 2003 Alexander JA, Lemak CH, Campbell CI
• Administrative burden and its implications for outpatient substance abuse treatment organizations.
  Psychiatric services (Washington, D.C.) 2003 Lemak CH, Alexander JA, Campbell C
• Culturally competent treatment practices and ancillary service use in outpatient substance abuse treatment.
  Journal of substance abuse treatment 2002 Campbell CI, Alexander JA